Open original FDA record ↗Recall record
- FDA identifier
- Z-0463-2022
- Company in FDA record
- Abbott Molecular, Inc.
- FDA record creation date
- Jan 6, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is an issue with the installation of updated camera firmware on the system.
Source facts
- Action
- On December 06, 2021 Abbott Molecular issued a Product Correction letter to all customers who received an Alinity m instrument impacted by this issue (List Number 08N53 002). Customers are being informed of a previously completed assessment conducted by Abbott FSEs. Customers were initially informed at the time of the assessment, but proper reconciliation of the communication was not performed. 100% of customers are requested to return to Abbott a Customer Reply Form acknowledging receipt and understanding, and/or a request for assistance. Abbott personnel will follow up with customers by e mailing and or follow up visits/phone calls.
- Initiated
- 2021-12-06
- Root cause
- Software design
- Terminated
- 2024-09-30
- Distribution
- Distribution in the United States in CA, DC, GA, KY, IL, MD, MI, MN, MS, NH, NJ, NY, RI, SD, TX, WI OUS distribution to Australia, Cambodia, Canada, Columbia, France, Germany, Israel, Italy, Malaysia, Mozambique, Portugal, South Africa, Spain, Switzerland, Taiwan, United Kingdom, and Vietnam
- Recall number
- Z-0463-2022
- Recall status
- Terminated
- CDRH record ID
- 190681
- FDA record created
- 2022-01-06
- Recall event number
- 89169